Pelvic endometriosis; treatment with methyl testosterone.

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (6)

• Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis 2001
• Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur®), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome 1997
• Endometriosis 1984
• Hormonal and Surgical Management of Pelvic Endometriosis 1982
• The Unsuspected Pelvic Factor in the Infertility Investigation 1980
• Conservative Treatment of Endometriosis: The Effects of Limited Surgery and Hormonal Pseudopregnancy 1976

Source provenance

europepmc

last seen: 2026-10-08T06:18:23.926119+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-14T05:59:49.008770+00:00